Tramadol Hydrochloride
Product Images NDC 33358-342

4 FDA label images from Rxchange Co. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 33358-342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxchange Co., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Rxchange Co. (33358-342-00) Tramadol 50mg, 100 Tablets (Rxchange Co. (33358 342 00) Tramadol 50mg, 100 Tablets)

Rxchange Co. (33358-342-00) Tramadol 50mg, 100 Tablets (Rxchange Co. (33358 342 00) Tramadol 50mg, 100 Tablets)
Label for Tramadol Hydrochloride 50mg tablets from RxChange Co., NDC 33358-342-00. The label indicates #100 tablets per bottle, classified as Schedule IV controlled substance (C4). Manufacturer listed as Amneal Pharmaceuticals of NY Hauppauge, NY 11788. Label includes lot number and expiration date placeholders, storage instructions, and warnings for prescription use only.*
FDA Label Image

7bb9a2e6-figure-01 (Tramadol HCl Tablets Usp 1)

7bb9a2e6-figure-01 (Tramadol HCl Tablets Usp 1)
Chemical structure of Tramadol Hydrochloride, showing molecular components including methoxyphenyl, cyclohexanol, and dimethylaminomethyl groups, along with the hydrochloride salt.*
FDA Label Image

7bb9a2e6-figure-02 (Tramadol HCl Tablets Usp 2)

7bb9a2e6-figure-02 (Tramadol HCl Tablets Usp 2)
A pharmacokinetic curve graph showing concentration (ng/mL) over time (hours) for Tramadol Hydrochloride and its metabolite M1 after single and multiple doses. Four curves illustrate the concentration-time profiles for Tramadol (multiple and single dose) and M1 (multiple and single dose) over a 48-hour period.*
FDA Label Image

7bb9a2e6-figure-03 (Tramadol HCl Tablets Usp 3)

7bb9a2e6-figure-03 (Tramadol HCl Tablets Usp 3)
A line chart titled 'Protocol CAPSS-047 Time to Discontinuation Due to Nausea/Vomiting' showing the percentage of subjects discontinuing over days in a double-blind study. The graph depicts a stepwise increase in discontinuation up to about 50 percent over 25 days at a dosage of 200 mg/day.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.